Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

138,961 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Corrigendum to "Characterization of common and rare mutations in EGFR and associated clinicopathological features in a large population of Chinese patients with lung cancer" [Pathology - Research and Practice 213 (2017) 749-758].
Wei B, Ren P, Zhang C, Wang Z, Dong B, Yang K, Zhao J, Tu S, Ma J, Guo Y. Wei B, et al. Among authors: wang z. Pathol Res Pract. 2017 Dec;213(12):1575. doi: 10.1016/j.prp.2017.11.007. Pathol Res Pract. 2017. PMID: 29167027 No abstract available.
Primary resistance to first- and second-generation ALK inhibitors in a non-small cell lung cancer patient with coexisting ALK rearrangement and an ALK F1174L-cis-S1189C de novo mutation: A case report.
Zhao J, Li X, Fan R, Qin Y, Wang Z, Wang B, Li S, Fan J, Wu X, Liu H, Guan Y, Liang Y, Zhang X, Guo Y. Zhao J, et al. Among authors: wang z, wang b. Front Pharmacol. 2022 Nov 23;13:1060460. doi: 10.3389/fphar.2022.1060460. eCollection 2022. Front Pharmacol. 2022. PMID: 36506539 Free PMC article.
138,961 results
You have reached the last available page of results. Please see the User Guide for more information.